Sign In
Buy HRMY
$32.10
+1.19 (+3.85%)
At Close: Jun 03, 2026
Harmony Biosciences to Participate in Upcoming Investor Conferences
09:00am, Wednesday, 27'th May 2026
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conferenc
Harmony Biosciences to Participate in Upcoming Investor Conferences
08:05am, Wednesday, 27'th May 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conference
Harmony Biosciences Holdings, Inc. (HRMY) Q1 2026 Earnings Call Transcript
06:11pm, Thursday, 07'th May 2026
Harmony Biosciences Holdings, Inc. (HRMY) Q1 2026 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates
09:56am, Thursday, 07'th May 2026
Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.55 per share, missing the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.78 per share a y
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today reported Q1 2026 revenue of $215.4 million, delivering 17% year‑over‑year growth for WAKIX®. Perfor
Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice
01:45pm, Monday, 04'th May 2026
Harmony Biosciences (HRMY) is well positioned to outperform the market, as it exhibits above-average growth in financials.
HRMY or ARGX: Which Is the Better Value Stock Right Now?
12:40pm, Monday, 04'th May 2026
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Harmony Biosciences Holdings, Inc. (HRMY) or argenex SE (ARGX). But which of these two stocks
Wall Street Analysts Think Harmony Biosciences (HRMY) Could Surge 34.81%: Read This Before Placing a Bet
10:56am, Monday, 04'th May 2026
The mean of analysts' price targets for Harmony Biosciences (HRMY) points to a 34.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement am
Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
08:05am, Thursday, 23'rd Apr 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report first quarter 2026 financial results on Thursday, May 7, 2026, before the
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will present encore open-label extension data from the company's investigation of EPX-
Harmony Biosciences Eyes $1B WAKIX Runway, Teases 2026 Pipeline Catalysts at Needham Conference
03:35am, Wednesday, 15'th Apr 2026
Harmony Biosciences (NASDAQ: HRMY) executives outlined 2026 priorities at Needham and Company's Virtual Healthcare Conference, emphasizing continued growth for WAKIX and multiple late-stage pipeline r
Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
04:51pm, Tuesday, 14'th Apr 2026
Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer
08:05am, Tuesday, 14'th Apr 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the appointment of Glenn Reicin as Chief Financial Officer, effective immediately, supporting
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board
08:05am, Thursday, 02'nd Apr 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the appointment of Peter Anastasiou as Chief Operating Officer and updates to its Board of Dir
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference
08:05am, Tuesday, 31'st Mar 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that Harmony's management team will participate in a fireside chat at the upcoming 25th Annual
